A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
References in this Annual Report on Form 10-K to “Amarin,” the “Company,” “we,” “our” and “us” refer to Amarin Corporation plc and its subsidiaries, on a consolidated basis, unless otherwise indicated. This Annual Report on Form 10-K, or Annual Report, includes the registered and unregistered trademarks and service marks of other parties. Amarin Corporation plc is a public limited company incorporated under the laws of England and Wales. Amarin Corporation plc was originally incorporated in England as a private limited company on March 1, 1989 under the Companies Act 1985, and re-registered in England as a public limited company on March 19, 1993. Our principal office is located at One Central Plaza, 8th Floor, 36 Dame Street, Dublin 2, Ireland. Our registered office is located at One New Change, London EC4M 9AF, England. Our primary office in the United States is located at 440 Route 22, Bridgewater, NJ 08807, USA. Our telephone number at that location is (908) 719-1315.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 214M | 214M | 229M | 307M | 369M | 583M |
| Net Income | -39M | -39M | -82M | -59M | -106M | 7.7M |
| EPS | $-0.09 | $-0.09 | $-4.00 | $-3.00 | $-5.20 | $0.40 |
| Free Cash Flow | 6.2M | 6.2M | -32M | 6.4M | -181M | -67M |
| ROIC | -12.0% | -8.2% | -16.9% | -10.7% | -17.8% | 3.6% |
| Gross Margin | 56.6% | 56.6% | 35.6% | 53.9% | 65.7% | 79.2% |
| Debt/Equity | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -50M | -50M | -92M | -68M | -106M | 11M |
| Operating Margin | -23.5% | -23.5% | -40.2% | -22.0% | -28.7% | 1.8% |
| ROE | -8.4% | -8.2% | -16.9% | -10.7% | -17.8% | 1.2% |
| Shares Outstanding | 431M | 431M | 21M | 20M | 20M | 19M |
AMARIN CORP PLC\UK passes 1 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 932.3x vs a median of 55.7x. The company's 5-year average gross margin is 58.2%. At current prices, the estimated annualized return to fair value is -51.4%.
AMARIN CORP PLC\UK (AMRN) has a 5-year average return on invested capital (ROIC) of -10.0%. This is below average and may indicate limited pricing power.
AMARIN CORP PLC\UK (AMRN) has a market capitalization of $6.3B. It is classified as a mid-cap stock.
AMARIN CORP PLC\UK (AMRN) does not currently pay a regular dividend.
AMARIN CORP PLC\UK (AMRN) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
AMARIN CORP PLC\UK (AMRN) reported annual revenue of $214 million in its most recent fiscal year, based on SEC EDGAR filings.
AMARIN CORP PLC\UK (AMRN) has a net profit margin of -18.2%. The company is currently unprofitable.
AMARIN CORP PLC\UK (AMRN) generated $6 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
AMARIN CORP PLC\UK (AMRN) has a debt-to-equity ratio of 0.01. This indicates a conservatively financed balance sheet.
AMARIN CORP PLC\UK (AMRN) reported earnings per share (EPS) of $-0.09 in its most recent fiscal year.
AMARIN CORP PLC\UK (AMRN) has a return on equity (ROE) of -8.2%. A negative ROE may indicate losses or negative equity.
AMARIN CORP PLC\UK (AMRN) has a 5-year average gross margin of 58.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 13 years of financial data for AMARIN CORP PLC\UK (AMRN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
AMARIN CORP PLC\UK (AMRN) has a book value per share of $1.07, based on its most recent annual SEC filing.
No recent press releases.